UPC deals further blow to Dexcom in glucose monitor dispute with Abbott

Paris Local Division revokes Dexcom patent and dismisses infringement action against rival | UPC revoked two other patents belonging to medical device company earlier in 2024.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Unified Patent Court

Dexcom suffers second patent revocation at hands of UPC

17 September 2024 The court rejected the medical device company’s auxiliary requests and nixed patent in 17 territories although it seems receptive to these amendments in general, say Laura Orlando and Rachel Montagnon of Herbert Smith Freehills.

Big Pharma

Delaware court sides with Abbott in glucose monitor dispute with DexCom

4 June 2024 Delaware judge denies DexCom’s motion to dismiss two counter-counterclaims in complex dispute with rival Abbott over glucose monitors | But judge also says Abbott is not entitled to further remedy.

Unified Patent Court

UPC’s second infringement decision revokes patent in Europe

9 July 2024 Pan-European court hands down second infringement decision | Revokes patent Europe-wide after counterclaim | DexCom and Abbott dispute over technology for remotely monitoring blood glucose levels in diabetes patients.